Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of ...

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

It’s still not clear what’s driving young-onset colorectal cancers. Suspected risk factors run the gamut from early ...

Acute myeloid leukemia, or AML, is a rare and aggressive cancer that can affect people of all ages. Kiran Vanaja, an ...

Cancer Grand Challenges, a global initiative co-founded by the National Cancer Institute in the US and Cancer Research UK, ...

BlackRock, the world's largest asset manager, has become the No. 2 shareholder of HLB. BlackRock said the move was "for simple investment purposes," but the market is focused on whether the U.S. Food ...

Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown by an ...

But quality-of-life findings should be considered alongside DFS benefit, says researcher ...

More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...

Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a clinical-stage biotechnology company developing a pipeline of proprietary small molecule ...

Learn about the innovative SHIELD blood test by Guardant Health that aims to detect colorectal cancer early, potentially revolutionizing cancer screening methods. Discover its availability, impact, ...